research & technology

Receptos leverages proprietary GPCR cell- and protein-based screening with receptor structure determination to enable rational drug development for high-value GPCR targets. Receptos has exclusively licensed breakthrough GPCR protein crystallization/structure determination technology from The Scripps Research Institute (TSRI) that was featured on the cover of Science in 2007 ("Technology") and has made significant advances to industrialize and apply the Technology to the discipline of drug discovery and development. The Technology is a central component of Receptos’ drug discovery engine which is focused on delivering best-in-class and first-in-class GPCR therapeutic candidates.
